Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem

The company has told countries that it can supply only 18.8 million of the 29.6 million doses it was contracted to deliver this year.

Related posts

U.S. to Review Social Media Posts of Student and Scholar Visa Applicants

Regulators Approve Lenacapavir for H.I.V. Prevention

When Humans Learned to Live Everywhere